HOUSTON, April 2, 2024 — Foundry JV Holdco LLC (the “Company”), a Delaware limited […]
Year: 2024
MILLER INDUSTRIES BOARD AUTHORIZES NEW SHARE REPURCHASE PROGRAM
CHATTANOOGA, Tenn., April 2, 2024 — Miller Industries, Inc. (NYSE: MLR) (“Miller Industries” or […]
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price
TEL AVIV, Israel and RALEIGH, N.C., April 2, 2024 — RedHill Biopharma Ltd. (Nasdaq: RDHL) […]
Mauser Announces Exchange Offer
OAK BROOK, Ill., April 1, 2024 — Mauser Packaging Solutions Holding Company (“Mauser“) today […]
BioLineRx Announces $6 Million Registered Direct Offering
TEL AVIV, Israel, April 1, 2024 — BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX) (“BioLineRx” […]
Announcement of Tender Offers for Any and All of the 2027 Notes and a portion of the 2028 Notes by Nexa Resources S.A.
LUXEMBOURG, April 1, 2024 — Nexa Resources S.A. (“Nexa Resources“, “Nexa” or the “Company“) (NYSE […]
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO’s Mother with Leading Fund Manager
RA’ANANA, Israel, April 1, 2024 — Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) […]
AERKOMM and Nasdaq-Listed IX Acquisition Corp. Announce Merger Agreement and US $35 Million Private Placement
SILICON VALLEY, Calif., March 29, 2024 — AERKOMM Inc. (Euronext: AKOM, OTCQX: AKOM, “AERKOMM”), an […]
Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds
NEW YORK, March 27, 2024 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical […]